Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Dipeptidyl Peptidase 4”

65 trials

Showing 20 of 65 results

Large-scale testing (Phase 3)Ended earlyNCT04371978
What this trial is testing

Efficacy and Safety of Dipeptidyl Peptidase-4 Inhibitors in Diabetic Patients With Established COVID-19

Who this might be right for
COVID 19CoronavirusDiabetes Mellitus, Type 2+12 more
Rabin Medical Center 64
Large-scale testing (Phase 3)Study completedNCT01822548
What this trial is testing

Effect of Vildagliptin vs. Glibenclamide on Circulating Endothelial Progenitor Cell Number Type 2 Diabetes

Who this might be right for
Type 2 Diabetes
Azienda Ospedaliero-Universitaria di Parma 64
Not applicableUnknownNCT04469582
What this trial is testing

The Association of Bullous Pemphigoid With Dipeptidyl-peptidase 4 Inhibitors

Who this might be right for
Bullous Pemphigoid
University of Athens 113
Post-approval studies (Phase 4)UnknownNCT01339143
What this trial is testing

Compare the Effect of DPP-IV Inhibitor or TZD on Glycemic Variability and Oxidative Stress in Patient With 2 Diabetes

Who this might be right for
Diabetes MellitusOxidative Stress
Korea University Anam Hospital 80
Testing effectiveness (Phase 2)Study completedNCT00111631
What this trial is testing

DPP-IV Inhibitor in Patients With Type 2 Diabetes

Who this might be right for
Diabetes Mellitus Type 2
Hoffmann-La Roche 218
Post-approval studies (Phase 4)UnknownNCT03458715
What this trial is testing

The Efficacy of Sodium-glucose Co-transporter 2 Inhibitor or Dipeptidyl Peptidase-4 Inhibitor in Type 2 Diabetes Patients With Premix Insulin

Who this might be right for
Type2 Diabetes
Mackay Memorial Hospital 120
Large-scale testing (Phase 3)Study completedNCT01189890
What this trial is testing

Safety and Efficacy of Sitagliptin Compared With Glimepiride in Elderly Participants With Type 2 Diabetes Mellitus (MK-0431-251)

Who this might be right for
Type 2 Diabetes Mellitus
Merck Sharp & Dohme LLC 480
Post-approval studies (Phase 4)UnknownNCT00699322
What this trial is testing

Effect of Dipeptidyl Peptidase-IV Inhibitor and Sulfonylurea on Glucose Variability and Oxidative Stress

Who this might be right for
Type 2 Diabetes
The Catholic University of Korea 36
Not applicableStudy completedNCT01682577
What this trial is testing

Bioequivalence Study of Two Formulations of Perindopril 4 mg Tablet Under Fasting Condition

Who this might be right for
Healthy
Dexa Medica Group 18
Post-approval studies (Phase 4)UnknownNCT02742233
What this trial is testing

Dipeptidyl Peptidase 4 Inhibition Facilitate Healing of Diabetic Ulcers

Who this might be right for
Diabetic Foot Ulcer
Long Min,MD 60
Not applicableUnknownNCT02148978
What this trial is testing

Cystic Fibrosis Related Diabetes

Who this might be right for
Cystic Fibrosis
Ram Weiss 30
Post-approval studies (Phase 4)Study completedNCT01701973
What this trial is testing

Effect of DPP4 Inhibition on Growth Hormone Secretion

Who this might be right for
Obesity
Vanderbilt University 44
Not applicableUnknownNCT02239458
What this trial is testing

DPP-IV Inhibition Prior to Development of Diabetes in Patients With Cystic Fibrosis

Who this might be right for
Cystic Fibrosis
Ram Weiss 60
Not applicableStudy completedNCT00843479
What this trial is testing

The Aging Endocrine Pancreas: Characterization of the Entero-insular Axis Physiology in the Elderly

Who this might be right for
Diabetes Mellitus, Type 2Insulin Resistance
University of Campinas, Brazil 24
Testing effectiveness (Phase 2)Study completedNCT00502710
What this trial is testing

Dipeptidyl-peptidase IV (DPP-IV) RO4876904 in Patients With Type 2 Diabetes.

Who this might be right for
Diabetes Mellitus Type 2
Hoffmann-La Roche 289
Testing effectiveness (Phase 2)Study completedNCT02683525
What this trial is testing

Sitagliptin for Prevention of Acute Graft Versus-Host Disease After Allogeneic Hematopoietic Stem Cell Transplantation

Who this might be right for
Graft vs Host DiseaseHematopoietic Stem Cell Transplantation
Sherif S. Farag 37
Post-approval studies (Phase 4)UnknownNCT02802644
What this trial is testing

The Effect of DPP4 Inhibitor on Vasclular Healing

Who this might be right for
Acute Coronary SyndromeDiabetes Mellitus, Type 2
Chung-Ang University 66
Large-scale testing (Phase 3)Study completedNCT00968708
What this trial is testing

Cardiovascular Outcomes Study of Alogliptin in Patients With Type 2 Diabetes and Acute Coronary Syndrome

Who this might be right for
Diabetes Mellitus, Type 2Acute Coronary Syndrome
Takeda 5,380
Not applicableStudy completedNCT03178019
What this trial is testing

DPP4 Activity, Microvascular Reactivity and Inflammation

Who this might be right for
OverweightPre DiabetesDiabetes Mellitus Type 2 Without Complication
Rio de Janeiro State University 52
Post-approval studies (Phase 4)Study completedNCT02941445
What this trial is testing

Weight Maintenance With Dipeptidyl Peptidase 4 (DPP4) Inhibitor Sitagliptin in Combination With Metformin After Liragludite Induced Weight Loss

Who this might be right for
Polycystic Ovary SyndromeBody Weight
University Medical Centre Ljubljana 24
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation